Press Releases

April 25, 2017

22nd Century Accepted to Present Proprietary Smoking Cessation Product at BIOCHINA Partnering Forum in Zhuhai, China (via Business Wire)

April 04, 2017

New Zealand Study Recommends 22nd Century’s VLN Cigarettes as an Effective Tobacco Control Strategy (via Business Wire)

March 30, 2017

22nd Century’s “Non- or Minimally-Addictive” Cigarettes Gaining Support of Leading Tobacco Scientists around the World (via Business Wire)

March 02, 2017

22nd Century Granted FDA Guidance Meeting for X-22 Smoking Cessation Aid (via Business Wire)

January 05, 2017

FDA Provides Positive and Encouraging Feedback for 22nd Century’s Very Low Nicotine MRTPA Filings (via Business Wire)

November 02, 2016

Mandating a Reduction in the Nicotine Content of Cigarettes Would Likely Decrease Both the Rate and Prevalence of Smoking (via Business Wire)

October 20, 2016

22nd Century’s Very Low Nicotine Cigarettes Significantly Reduce Withdrawal and Craving Symptoms in Vulnerable Population Groups (via Business Wire)

October 13, 2016

22nd Century Very Low Nicotine Cigarettes Could Reduce U.S. Smoking Rates by More than 75% (via Business Wire)

September 27, 2016

Overwhelming Physician and Consumer Support Cited for 22nd Century’s “X-22” Very Low Nicotine Smoking Cessation Product (via Business Wire)

July 14, 2016

Nicotine Reduction Strategy is Championed by Growing Number of Scientists and Public Health Experts (via Business Wire)

July 11, 2016

World Health Organization Recommends “Mandated Reductions in Nicotine to Minimally Addictive Levels” (via Business Wire)

June 28, 2016

22nd Century’s Very Low Nicotine Cigarettes Reduce Smoking and Are Now Associated with Reduced Alcohol Use (via Business Wire)

June 22, 2016

New Study Shows Cigarettes Containing 22nd Century’s Proprietary Tobacco Reduce Smoking and Toxicant Exposure (via Business Wire)

June 16, 2016

22nd Century’s Proprietary SPECTRUM® Cigarettes Identified as Crucial Tool in Human Addiction Studies (via Business Wire)

May 27, 2016

22nd Century Presents at Hofstra Northwell School of Medicine; Reveals New Initiative to Engage Health Care Professionals (via Business Wire)

May 24, 2016

Independent Phase II and III Clinical Studies on 22nd Century’s Smoking Cessation Technology Highlighted on New Heracles Website (via Business Wire)

May 19, 2016

22nd Century to Make Proprietary Research Cigarettes Available Worldwide to Scientists, Researchers, and Governments (via Business Wire)

May 06, 2016

22nd Century to Call for National Tobacco Harm Reduction Policy at Tobacco Merchants’ Association National Conference (via Business Wire)

April 18, 2016

Pioneer of Altered Nicotine Tobacco to Give Keynote Address at 22nd Century Group’s Annual Shareholder Meeting (via Business Wire)

March 31, 2016

FDA Acknowledges Receipt of 22nd Century’s Very Low Nicotine Modified Risk Tobacco Product Application (via Business Wire)

March 10, 2016

Fifteen Scientific Studies with 22nd Century’s Reduced Nicotine SPECTRUM® Cigarettes Presented at the Society for Research on Nicotine & Tobacco 2016 Annual Meeting (via Business Wire)

February 24, 2016

New Zealand Medical Journal Publishes Letter Recommending 22nd Century’s Very Low Nicotine Cigarettes as Important Smoking Reduction Tool (via Business Wire)

January 26, 2016

22nd Century Delivers 4.95 Million SPECTRUM® Cigarettes for the National Institute on Drug Abuse (via Business Wire)

January 19, 2016

22nd Century Meets with FDA on Historic Modified Risk Tobacco Product Application for World’s Lowest Nicotine Tobacco Cigarettes (via Business Wire)

January 04, 2016

22nd Century Files Modified Risk Tobacco Product Application with the FDA for World’s Lowest Nicotine Tobacco Cigarettes (via Business Wire)

November 24, 2015

22nd Century Group to Open Laboratories to Lower Costs of Research and Speed Development of Important New Products (via Business Wire)

October 15, 2015

22nd Century Announces New Cannabis Research Collaboration with Anandia Laboratories (via Business Wire)

October 08, 2015

22nd Century Announces Hiring of Key Executive; Dr. Paul J. Rushton Will Spearhead Growth and Commercialization of 22nd Century’s Plant Biotechnology Portfolio (via Business Wire)

October 02, 2015

The New England Journal of Medicine Publishes Landmark Study Using 22nd Century’s Proprietary Very Low Nicotine Cigarettes (via Business Wire)

September 24, 2015

22nd Century Presents Potential Reduced Exposure Tobacco Cigarettes at National Tobacco Science Research Conference (via Business Wire)

September 09, 2015

22nd Century Group Receives Order for Nearly 5 Million SPECTRUM® U.S. Government Research Cigarettes (via Business Wire)

September 08, 2015

22nd Century Announces Strategic Hire to Facilitate FDA Applications for Modified Risk Tobacco Product Candidates (via Business Wire)

September 03, 2015

Very Low Nicotine Cigarettes: A Game-Changer for the Tobacco Industry (via Business Wire)

June 17, 2015

Phase II Clinical Trial Featuring 22nd Century’s Very Low Nicotine Tobacco Accepted for Publication (via Business Wire)

April 16, 2015

22nd Century Group Announces Launch of “0.0 mg Nicotine” MAGIC Cigarettes in Spain (via Business Wire)

March 25, 2015

Professor David Sweanor to Give Keynote Address at 22nd Century Group Annual Shareholder Meeting; Company Releases Letter to Shareholders (via Business Wire)